Atlas Trials

Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide

Clinical trial NCT03756116 · UNKNOWN

Trial details

NCT number
NCT03756116
Sponsor
The Second Hospital of Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Post-ERCP Acute PancreatitisEpinephrine
Start date
2018-10-01
Primary completion
2020-10-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.